BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37751969)

  • 1. Incidental DCIS within a fibroadenoma.
    Chen A; Kanakaratne S; Britten-Jones P; Bingham J
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37751969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative diagnosis of ductal carcinoma in situ arising within a mammary fibroadenoma: a case report.
    Ooe A; Takahara S; Sumiyoshi K; Yamamoto H; Shiba E; Kawai J
    Jpn J Clin Oncol; 2011 Jul; 41(7):918-23. PubMed ID: 21693482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade ductal carcinoma in situ (DCIS) arising in a fibroadenoma of the breast during 5 years follow-up: A case report.
    Shojaku H; Hori R; Yoshida T; Matsui K; Shimada K; Takayanagi N; Noguchi K
    Medicine (Baltimore); 2021 Mar; 100(10):e24023. PubMed ID: 33725814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Core Wash Cytology: A reliable same day biopsy result for breast clinics.
    Bulte JP; Wauters CA; Duijm LE; de Wilt JH; Strobbe LJ
    Eur J Surg Oncol; 2016 Dec; 42(12):1821-1826. PubMed ID: 27450639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy.
    Srour MK; Donovan C; Chung A; Harit A; Dadmanesh F; Giuliano AE; Amersi F
    Breast J; 2020 Apr; 26(4):679-684. PubMed ID: 31562689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report and Review of Adolescent Atypical Ductal Hyperplasia and Juvenile Fibroadenoma: How Do We Assess and Manage Future Risk?
    Gandhi S; Sudheendra P; Rafferty W; Loveland-Jones C
    Clin Breast Cancer; 2018 Oct; 18(5):e751-e754. PubMed ID: 30131245
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma.
    Kato F; Omatsu T; Matsumura W; Takahashi M; Hosoda M; Takahashi H; Kubota K; Oyama-Manabe N; Terae S; Shirato H
    Magn Reson Med Sci; 2011; 10(2):129-32. PubMed ID: 21720115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Uncommon Pairing of common Tumors: Case Report of Ductal Carcinoma
    Marumoto A; Steinemann S; Furumoto N; Woodruff S
    Hawaii J Med Public Health; 2019 Feb; 78(2):39-43. PubMed ID: 30766763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of immunocytochemistry using cocktail antibody targeting p63/cytokeratin14 for the differential diagnosis of fibroadenoma and ductal carcinoma in situ in fine needle aspiration cytology of the breast.
    Maeda I; Oana Y; Tsugawa K; Takagi M
    Cytopathology; 2017 Oct; 28(5):378-384. PubMed ID: 28685877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the frequency of upgrade to malignancy following surgical excision of high-risk breast lesions and ductal carcinoma in situ identified by core needle biopsy.
    Allen A; Cauthen A; Dale P; Jean-Louis C; Lord A; Smith B
    Breast J; 2019 Jan; 25(1):103-106. PubMed ID: 30461129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of extracellular mucin in breast fine needle aspiration specimens.
    Shield PW; Ribu DL; Cominos D
    Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal and lobular carcinoma in situ arising within an enlarging biopsy proven fibroadenoma.
    Feliciano YZ; Freire R; Net J; Yepes M
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33468635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental intraductal papillomas (<2 mm) of the breast diagnosed on needle core biopsy do not need to be excised.
    Jaffer S; Bleiweiss IJ; Nagi C
    Breast J; 2013; 19(2):130-3. PubMed ID: 23336823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroadenoma in axillary ectopic breast.
    Tee SW; Tan YH; Jeyabalan D; Selvam D
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35272989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors.
    Saimura M; Koga K; Anan K; Mitsuyama S; Tamiya S
    Breast Cancer; 2018 Jul; 25(4):470-478. PubMed ID: 29460095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.
    Vandenbussche CJ; Khouri N; Sbaity E; Tsangaris TN; Vang R; Tatsas A; Cimino-Mathews A; Argani P
    Am J Surg Pathol; 2013 Jun; 37(6):913-23. PubMed ID: 23598968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.
    Chae BJ; Lee A; Song BJ; Jung SS
    World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
    Allen SD; Osin P; Nerurkar A
    Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
    Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
    Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
    Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
    BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.